扩大外科团队质量改进(QIST):避免手术部位感染与贫血的整群随机对照试验方案
该整群随机对照试验将40家信托机构按1:1随机分配,分别引入基于突破系列协作模式的改进协作,以推行MSSA去定植或贫血优化方案。主要结局分别为术后90天内深部MSSA手术部位感染和术后7天内输血。
要点
- 40家Trusts按1:1随机,分别实施MSSA去定植或贫血优化质量改进协作。
- 主要结局:感染组为术后90天内深部MSSA手术部位感染,贫血组为术后7天内输血。
- 患者层面次要结局包括住院时间和再入院,用于经济成本评估。
核心结论
- 该试验旨在评估基于突破系列协作模式的质量改进协作在NHS大规模推广服务改进的有效性和成本效果。
研究设计与样本
- 整群随机对照试验,40家Trusts按1:1随机分配至两种已证明可改善择期全髋和膝关节置换患者结局的方案之一。
关键数值与推荐
- QIST:感染协作的主要结局为术后90天内深部MSSA手术部位感染。
- QIST:贫血协作的主要结局为术后7天内输血。
临床怎么用
- 通过质量改进协作支持Trusts大规模引入MSSA去定植或贫血优化方案,未引入的方案继续常规实践。
局限性
- 试验规模带来招募和维持多达40家组织的挑战,每家组织有其自身文化和背景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Measures shown to improve outcomes for patients often fail to be adopted into routine practice in the NHS. The Institute for Health Improvement Breakthrough Series Collaborative (BSC) model is designed to support implementation at scale. This trial aims to assess the effectiveness and cost-effectiveness of quality improvement collaboratives (QICs) based on the BSC method for introducing service improvements at scale in the NHS. METHODS: Forty Trusts will be randomised (1:1) to introduce one of two protocols already shown to improve outcomes in patients undergoing elective total hip and knee replacement surgery. The intervention is improvement collaboratives based on the BSC model, a learning system that brings together a large number of teams to seek improvement focussed on a proven intervention. Collaboratives aim to deliver at scale, maximise local engagement and leadership and are designed to build capacity, enable learning and prepare for sustainability. Collaboratives involve Learning Sessions, Action Periods, and a summative congress. Trusts will be supported to introduce either: decolonisation for Methicillin Sensitive Staphylococcus aureus (MSSA) to reduce post-operative infection (QIST: Infection), or an anaemia optimisation programme to reduce peri-operative blood transfusions (QIST: Anaemia). Trusts will continue with their usual practice for whichever protocol they are not introducing. Anonymised data related to both infection and anaemia outcomes for patients undergoing hip or knee arthroplasty at all sites will mean that the two groups act as controls for each other. The primary outcome for the QIST: Infection collaborative is deep MSSA surgical site infection within 90 days of surgery, and for the QIST: Anaemia collaborative is blood transfusion within 7 days of surgery. Patient-level secondary outcomes include length of hospital stay and readmission, which will also inform the economic costings. Qualitative interviews will evaluate the support provided to teams. DISCUSSION: The scale of this trial brings considerable challenges and potential barriers to delivery. Anticipated challenges relate to recruiting and sustaining up to 40 organisations, each with its own culture and context. This complex project with multiple stakeholders across a large geographical area will be managed by experienced senior-level project leaders with a proven track record in advanced project management. The team should ensure effective project governance and communications. TRIAL REGISTRATION: ISRCTN, ISRCTN11085475. Prospectively registered on 15 February 2018.
引用
- Scrimshire AB, Booth A, Fairhurst C, et al. Scaling up Quality Improvement for Surgical Teams (QIST) - avoiding surgical site infection and anaemia at the time of surgery: protocol for a cluster randomised controlled trial. Trials. 2020. PMID: 32111244. doi:10.1186/s13063-020-4152-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。